FI981710A0 - Terapeuttisesti käyttökelpoiset 1,2,3,3a,8,8a-heksahydro-1,3a,8-trimetyylipyrrolo/2,3-b/indol-5-yylijohdannaiset - Google Patents

Terapeuttisesti käyttökelpoiset 1,2,3,3a,8,8a-heksahydro-1,3a,8-trimetyylipyrrolo/2,3-b/indol-5-yylijohdannaiset

Info

Publication number
FI981710A0
FI981710A0 FI981710A FI981710A FI981710A0 FI 981710 A0 FI981710 A0 FI 981710A0 FI 981710 A FI981710 A FI 981710A FI 981710 A FI981710 A FI 981710A FI 981710 A0 FI981710 A0 FI 981710A0
Authority
FI
Finland
Prior art keywords
trimethylpyrrolo
hexahydro
indol
therapeutically useful
chem
Prior art date
Application number
FI981710A
Other languages
English (en)
Swedish (sv)
Other versions
FI981710A (fi
Inventor
Denise Mary Flanagan
Lawrence Leo Martin
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of FI981710A0 publication Critical patent/FI981710A0/fi
Publication of FI981710A publication Critical patent/FI981710A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Fats And Perfumes (AREA)
FI981710A 1991-10-01 1998-08-06 Terapeuttisesti käyttökelpoiset 1,2,3,3a,8,8a-heksahydro-1,3a,8-trimetyylipyrrolo/2,3-b/indol-5-yylijohdannaiset FI981710A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/769,268 US5153193A (en) 1991-10-01 1991-10-01 Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs

Publications (2)

Publication Number Publication Date
FI981710A0 true FI981710A0 (fi) 1998-08-06
FI981710A FI981710A (fi) 1998-08-06

Family

ID=25084962

Family Applications (2)

Application Number Title Priority Date Filing Date
FI924370A FI102178B1 (fi) 1991-10-01 1992-09-29 Menetelmä terapeuttisesti käyttökelpoisten 1,2,3,3a,8,8a-heksahydro-1,3a,8-trimetyylipyrrolo[2,3-b]indol-5-yylijohdannaisten valmistamiseksi
FI981710A FI981710A (fi) 1991-10-01 1998-08-06 Terapeuttisesti käyttökelpoiset 1,2,3,3a,8,8a-heksahydro-1,3a,8-trimetyylipyrrolo/2,3-b/indol-5-yylijohdannaiset

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI924370A FI102178B1 (fi) 1991-10-01 1992-09-29 Menetelmä terapeuttisesti käyttökelpoisten 1,2,3,3a,8,8a-heksahydro-1,3a,8-trimetyylipyrrolo[2,3-b]indol-5-yylijohdannaisten valmistamiseksi

Country Status (21)

Country Link
US (1) US5153193A (fi)
EP (2) EP0535645B1 (fi)
JP (1) JP2703157B2 (fi)
KR (2) KR100276143B1 (fi)
AT (1) ATE201024T1 (fi)
AU (1) AU649882B2 (fi)
CA (1) CA2079548C (fi)
CZ (1) CZ281982B6 (fi)
DE (1) DE69231817T2 (fi)
DK (1) DK0535645T3 (fi)
ES (1) ES2157201T3 (fi)
FI (2) FI102178B1 (fi)
GR (1) GR3036334T3 (fi)
HU (1) HU215120B (fi)
IL (1) IL103304A (fi)
MX (1) MX9205577A (fi)
NO (1) NO301884B1 (fi)
NZ (1) NZ244540A (fi)
PT (1) PT535645E (fi)
RU (1) RU2103271C1 (fi)
TW (1) TW208009B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231093A (en) * 1991-10-01 1993-07-27 Hoechst-Roussel Pharmaceuticals Incorporated Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs
IT1253007B (it) * 1991-12-31 1995-07-10 Aesculapius Farma Srl Derivati dell'eserolina ad attivita' anticolinesterasica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
US5480651A (en) * 1992-03-16 1996-01-02 Regents Of The University Of California Composition and method for treating nicotine craving in smoking cessation
US6316439B1 (en) 1993-10-15 2001-11-13 Aventis Pharamaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
US6323195B1 (en) * 1993-10-15 2001-11-27 Aventis Pharmaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
US6323196B1 (en) * 1993-10-15 2001-11-27 Aventis Pharmaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
AT403803B (de) * 1996-04-19 1998-05-25 Sanochemia Ltd Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
US5665880A (en) * 1996-10-31 1997-09-09 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseretholes
US5677457A (en) * 1996-12-19 1997-10-14 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseroline ethers
WO2000059544A1 (fr) * 1999-03-31 2000-10-12 Eisai Co., Ltd. Compositions stabilisees contenant des medicaments nootropes
DE50101827D1 (de) * 2000-03-31 2004-05-06 Sanochemia Pharmazeutika Ag Wi Neue derivate und analoga von galanthamin
AU2001217709B2 (en) * 2000-11-16 2005-10-13 Alcon Manufacturing, Ltd. Combination therapy for lowering and controlling intraocular pressure
WO2005042475A2 (en) * 2003-10-21 2005-05-12 Sention, Inc. Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
US7549431B1 (en) * 2004-11-10 2009-06-23 Gore Enterprise Holdings, Inc. Protective enclosure
TWI487486B (zh) 2009-12-01 2015-06-11 Syngenta Participations Ag 以異唑啉衍生物為主之殺蟲化合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1974782U (de) 1967-07-04 1967-12-14 Filzfabrik Fulda G M B H & Co Matratzenschoner.
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
DE3856594D1 (de) * 1987-05-04 2008-11-27 Bonnie Davis Mittel zur behandlung der alzheimer-krankheit
GB8727792D0 (en) * 1987-11-27 1987-12-31 Merck Sharp & Dohme Therapeutic agents
GB8823605D0 (en) * 1988-10-07 1988-11-16 Merck Sharp & Dohme Therapeutic agents
US5187171A (en) * 1989-01-09 1993-02-16 G. D. Searle & Co. Use of a glycine b partial agonist as an antipsychotic
US5061721A (en) * 1989-03-15 1991-10-29 G. D. Searle & Co. Composition containing d-cycloserine and d-alanine for memory and learning enhancement or treatment of a cognitive or psychotic disorder
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use

Also Published As

Publication number Publication date
EP0535645A2 (en) 1993-04-07
HUT65277A (en) 1994-05-02
ES2157201T3 (es) 2001-08-16
HU9203129D0 (en) 1992-12-28
FI924370A0 (fi) 1992-09-29
NO923803D0 (no) 1992-09-30
EP1069125A2 (en) 2001-01-17
RU2103271C1 (ru) 1998-01-27
IL103304A (en) 1996-12-05
JP2703157B2 (ja) 1998-01-26
FI102178B (fi) 1998-10-30
FI924370A (fi) 1993-04-02
DK0535645T3 (da) 2001-08-13
EP0535645A3 (en) 1993-08-04
HU215120B (hu) 1998-09-28
KR100271416B1 (en) 2000-11-15
NO301884B1 (no) 1997-12-22
CA2079548A1 (en) 1993-04-02
GR3036334T3 (en) 2001-11-30
CZ299092A3 (en) 1993-10-13
ATE201024T1 (de) 2001-05-15
EP0535645B1 (en) 2001-05-09
KR100276143B1 (ko) 2001-03-02
JPH05194519A (ja) 1993-08-03
AU2606592A (en) 1993-04-08
FI102178B1 (fi) 1998-10-30
NZ244540A (en) 1995-04-27
FI981710A (fi) 1998-08-06
DE69231817D1 (de) 2001-06-13
DE69231817T2 (de) 2001-09-27
NO923803L (no) 1993-04-02
AU649882B2 (en) 1994-06-02
KR930007947A (ko) 1993-05-20
IL103304A0 (en) 1993-02-21
TW208009B (fi) 1993-06-21
MX9205577A (es) 1993-04-01
CZ281982B6 (cs) 1997-04-16
PT535645E (pt) 2001-09-27
EP1069125A3 (en) 2001-10-10
US5153193A (en) 1992-10-06
CA2079548C (en) 2002-03-19

Similar Documents

Publication Publication Date Title
FI981710A (fi) Terapeuttisesti käyttökelpoiset 1,2,3,3a,8,8a-heksahydro-1,3a,8-trimetyylipyrrolo/2,3-b/indol-5-yylijohdannaiset
DK0402752T3 (da) N-Heteroaryl-purin-6-aminer, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
ZA909590B (en) Aminocarbonylcarbamates related to physostigmine,a process for their preparation and their use as medicaments
NO177145C (no) Analogifremgangsmåte for fremstilling av 4,5,6,7-tetrahydroisotiazolo[4,5-cÅ-pyridinderivater og isomere
NO162859C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oksadiazolylimidazobenzodiazepinforbindelser.
MA21932A1 (fr) Procede de preparation de nouveaux composes .